2025年医疗保健品牌榜_38页_5mb
报告摘要
- Brand Finance's 2025 Healthcare report evaluates the top brands in pharmaceuticals, medical devices, and healthcare services based on financial valuation and brand strength.
- Pharmaceuticals: Johnson & Johnson remains the most valuable brand ($15.5 billion, 16% growth), while Lilly grows fastest (36% to $8 billion) due to weight loss drugs.
- Medical Devices: Medtronic surpasses Fresenius as the top brand, aided by product recovery and new offerings.
- Healthcare Services: UnitedHealthcare is the only brand with value growth (14%), despite sector-wide declines driven by market pressures and controversies.
- Brand Strength Index (BSI): Johnson & Johnson (83.5/100) and Bayer (82/100) lead in pharmaceuticals, while Philips (87.8/100) dominates medical devices. UnitedHealthcare (84.8/100) is the strongest in services.
- Key trends include weight loss drug innovation boosting pharma values, AI and digital advancements in devices, and sustainability influencing brand perceptions.
- Healthcare Services face scrutiny and lower sentiment, with public events like the murder of Brian Thompson noted.
- Hospitals: Global Top 250 list highlights institutions like Johns Hopkins and Mayo Clinic, emphasizing research and patient care excellence.
- Brand Guardianship Index assesses CEO effectiveness, with Siemens Healthineers' Bernd Montag ranking top in healthcare.
- Methodology uses a "Royalty Relief" approach based on ISO 10668, combining brand impact, strength, and future revenue forecasts for valuation.
- Challenges include sector consolidation, pricing transparency debates, and declining public trust in healthcare services brands.
- Sustainability is a growing factor in brand valuation, particularly in pharmaceuticals, with companies like Lilly showing strong ESG perceptions.
展开完整摘要
试读结束，高清完整版pdf/doc/ppt,请点下载
